14 Citations (Scopus)

Abstract

Immunotherapy of cancer using chimeric antigen receptor-engineered T-cells has transformed the management of selected haematological malignancies, triggering intense clinical trial activity in this arena. This article summarises trial activity that has been published to date across the spectrum of haematological and solid tumour types.

Original languageEnglish
Article numberltab004
JournalImmunotherapy advances
Volume1
Issue number1
DOIs
Publication statusPublished - 1 Jan 2021

Keywords

  • cancer
  • CAR T-cell
  • clinical trials
  • immunotherapy

Fingerprint

Dive into the research topics of 'An overview of CAR T-cell clinical trial activity to 2021'. Together they form a unique fingerprint.

Cite this